Ozempic (Semaglutide) Ozempic (semaglutide), along with diet and exercise, helps improve blood sugar in adults with type 2 diabetes
FDA regulatory status - compounded GLP-1s: FDA proposed April 30, 2026 to exclude semaglutide and tirzepatide from 503B Bulks List
GLP ones may have benefits for cardiovascular disease, for, uh, metabolic disease
Hair loss is not listed as a known or direct adverse effect in the FDA prescribing information for Ozempic (semaglutide) or Wegovy (semaglutide for weight management)
The authors, who included Krista Huybrechts of Brigham and Women's Hospital and Harvard Medical School, said these findings may provide some reassurance for women with unintentional first-trimester exposure to GLP-1s
If youre on a GLP-1 medication such as semaglutide (Ozempic) or tirzepatide (Mounjaro) for type 2 diabetes, or semaglutide (Wegovy), tirzepatide (Zepbound), or orforglipron (Foundayo) for weight loss, you probably know that your food and beverage choices make a big difference in how well you do on these drugs